1. Comprehensively prognostic and immunological analysis of VRK Serine/Threonine Kinase 1 in pan-cancer and identification in hepatocellular carcinoma
   Dongxing Chen et al, 2023, Aging CrossRef
2. Interaction of obtusilactone B and related butanolide lactones with the barrier-to-autointegration factor 1 (BAF1). A computational study
   Christian Bailly et al, 2021, Current Research in Pharmacology and Drug Discovery CrossRef
3. Proteomics Studies Suggest That Nitric Oxide Donor Furoxans Inhibit In Vitro Vascular Smooth Muscle Cell Proliferation by Nitric Oxide-Independent Mechanisms
   Loretta Lazzarato et al, 2023, Molecules CrossRef
4. Inactivation of VRK1 sensitizes ovarian cancer to PARP inhibition through regulating DNA-PK stability
   Do Yeon Kim et al, 2024, Experimental Cell Research CrossRef
5. Molecular docking of brazilin and its analogs to barrier‐to‐autointegration factor 1 (BAF1)
   Maria de Nazaré Correia Soeiro et al, 2022, Annals of the New York Academy of Sciences CrossRef
6. VRK1 Is a Synthetic–Lethal Target in VRK2-Deficient Glioblastoma
   Julie A. Shields et al, 2022, Cancer Research CrossRef
7. Inhibition of VRK1 suppresses proliferation and migration of vascular smooth muscle cells and intima hyperplasia after injury via mTORC1/β-catenin axis
   Xiongshan Sun et al, 2022, BMB Reports CrossRef
8. A Review of the Regulatory Mechanisms of N-Myc on Cell Cycle
   Hong-Li Li et al, 2023, Molecules CrossRef
9. Identification of BANF1 as a novel prognostic biomarker in gastric cancer and validation via in-vitro and in-vivo experiments
   Yuanmin Xu et al, 2024, Aging CrossRef